Company
Director: Wang Wenxiong; Chief Executive Officer: Xia Yiteng; Chief Financial Officer: Sun Anqi; Technical Advisor: Wang Sishi; Secretary: Candy Lua
Description
Our company is called Cellment Biotech Company Limited, established in 2023. It is a startup funded by the HKT300 entrepreneurship grant from City University of Hong Kong. We have developed a rapid toxicity testing and assessment technology using the research capabilities of City University. This technology not only eliminates the need for using laboratory animals but also offers faster testing, lower costs, and requires smaller sample sizes. The technology has applied for a U.S. patent and has been published in scientific journals. So far, we have provided testing services to three companies and two university laboratories.
